Integrated Core Strategies (US) LLC 13D and 13G filings for Mersana Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2023-01-19 4:06 pm Sale |
2022-12-31 | 13G | Mersana Therapeutics, Inc. MRSN |
Integrated Core Strategies (US) LLC | 3,663,527 3.700% |
-67,184![]() (-1.80%) |
Filing |
2022-02-17 4:12 pm Purchase |
2022-02-15 | 13G | Mersana Therapeutics, Inc. MRSN |
Integrated Core Strategies (US) LLC | 3,730,711 5.200% |
3,730,711![]() (New Position) |
Filing |